Results 211 to 220 of about 5,603,208 (256)
Some of the next articles are maybe not open access.
Postgraduate Medicine, 1965
Mercury strain-gauge plethysmography is a simple, reliable and relatively inexpensive technic for office diagnosis and evaluation of patients with peripheral arterial disease. This method also can be applied to study of smaller arteries and sympathetic nervous system activity and evaluation of diabetic patients with peripheral neuropathy.
openaire +2 more sources
Mercury strain-gauge plethysmography is a simple, reliable and relatively inexpensive technic for office diagnosis and evaluation of patients with peripheral arterial disease. This method also can be applied to study of smaller arteries and sympathetic nervous system activity and evaluation of diabetic patients with peripheral neuropathy.
openaire +2 more sources
Disease-a-Month, 1994
Peripheral arterial diseases are common problems because atherosclerosis, the most common cause of both occlusive peripheral arterial disease and aneurysmal disease, is a feature of an aging population. The less common types of occlusive peripheral arterial disease--the vasospastic disorders and the arteritides--although frequently not addressed to any
openaire +2 more sources
Peripheral arterial diseases are common problems because atherosclerosis, the most common cause of both occlusive peripheral arterial disease and aneurysmal disease, is a feature of an aging population. The less common types of occlusive peripheral arterial disease--the vasospastic disorders and the arteritides--although frequently not addressed to any
openaire +2 more sources
Heart, Lung and Circulation, 2018
Peripheral arterial disease (PAD) affects 15% of the Australian population and is a powerful and serious predictor of cardiovascular mortality yet continues to be under-recognised and undertreated. Diagnosis is simple and management is centred upon symptom relief and risk minimisation.
Sean M, Conte, Peter R, Vale
openaire +2 more sources
Peripheral arterial disease (PAD) affects 15% of the Australian population and is a powerful and serious predictor of cardiovascular mortality yet continues to be under-recognised and undertreated. Diagnosis is simple and management is centred upon symptom relief and risk minimisation.
Sean M, Conte, Peter R, Vale
openaire +2 more sources
Antioxidants in Peripheral Arterial Disease
Current Drug Target -Cardiovascular & Hematological Disorders, 2004Peripheral arterial disease (PAD) is an important manifestation of systemic atherosclerosis that is characterized by obstruction of the arteries in the lower limbs. Experimental and epidemiological studies suggest a key role for oxidative stress in initiation and progression of the atherosclerotic process.
VIOLI, Francesco +2 more
openaire +3 more sources
The Lancet, 2001
Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during ambulation, which is known as "intermittent claudication". Some relief of symptoms is possible with exercise, pharmacotherapy, and cessation of smoking.
openaire +2 more sources
Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during ambulation, which is known as "intermittent claudication". Some relief of symptoms is possible with exercise, pharmacotherapy, and cessation of smoking.
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 1999
Risk factors for atherosclerosis should be identified and reduced in all patients who have peripheral arterial disease. Cessation of smoking, strict control of diabetes and hypertension, and aggressive reduction in low-density lipoprotein cholesterol level result in a slowdown of disease progression and a reduction in cardiovascular events.
openaire +2 more sources
Risk factors for atherosclerosis should be identified and reduced in all patients who have peripheral arterial disease. Cessation of smoking, strict control of diabetes and hypertension, and aggressive reduction in low-density lipoprotein cholesterol level result in a slowdown of disease progression and a reduction in cardiovascular events.
openaire +2 more sources
Cardiology Clinics, 2011
co m The last decade has seen a tremendous surge of interest in peripheral arterial disease (PAD). The prevalence of multiple risk factors, chronic nature of disease, the nonspecificity of symptoms, and lackof adequate treatment optionshaveall contributed to the large burden of disease, which is frequently unrecognized.
openaire +2 more sources
co m The last decade has seen a tremendous surge of interest in peripheral arterial disease (PAD). The prevalence of multiple risk factors, chronic nature of disease, the nonspecificity of symptoms, and lackof adequate treatment optionshaveall contributed to the large burden of disease, which is frequently unrecognized.
openaire +2 more sources
Antioxidants in Peripheral Arterial Disease
Current Drug Targets, 2003Peripheral arterial disease (PAD) is an important manifestation of systemic atherosclerosis that is characterized by obstruction of the arteries in the lower limbs. Experimental and epidemiological studies suggested a key role for oxidative stress in initiation and progression of the atherosclerotic process. The results of these studies provided a good
F, Violi +3 more
openaire +2 more sources
Cilostazol and peripheral arterial disease
Expert Opinion on Pharmacotherapy, 2008Peripheral arterial disease is both common and disabling. Contemporary management of peripheral arterial disease is multimodal, encompassing both medical and interventional treatments. Cilostazol (Pletal), a 2-oxoquinolone derivative, is currently licensed in the UK for the treatment of patients with intermittent claudication to improve their walking ...
Lyndsay, Pearce +3 more
openaire +2 more sources
Mitochondriopathy of Peripheral Arterial Disease
Vascular, 2007The signs and symptoms of peripheral arterial occlusive disease (PAD), including claudication, rest pain, and tissue loss, are consequences of compromised bioenergetics and oxidative tissue injury within the affected lower extremities. Compromised bioenergetics is the result of a combination of low blood flow through diseased arteries and diminished ...
Konstantinos I, Makris +7 more
openaire +2 more sources